MAR 2 4 :976
S018

DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE
PUBLIC HEALTH SERVICE
NATIONAL INSTITUTES OF HEALTH
BETHESDA, MARYLAND 20014

 

March 14, 1975 NATIONAL HEART AND LUNG INSTITUTE

Dr. Joshua Lederberg

Professor of Genetics

Stanford University Medical Center
Stanford, California 94305

Dear Dr. Lederberg:

Your request for information on membrane oxygenators was referred to
me from the Public Inquiries and Reports Branch of the National Insti-
tutes of Health. The Division of Lung Diseases of the National Heart
and Lung Institute is currently supporting a collaborative clinical
program to determine the indications for the use of the membrane oxy-
genator and its efficacy for the support of patients with acute res-
piratory failure.

I have enclosed a copy of our clinical protocol and a list of partici-
pating centers. I have also enclosed several reprints of articles

which should provide you with background information including the

latest summary of world experience (Dr. Gille) and the largest experience
in the United States (Dr. Hill) as well as information on some of the
technical advances and problems associated with long-term membrane
oxygenation.

Several phone attempts to determine your specific informational needs
were unsuccessful. I hope that this material suits your requirements.
Please do not hesitate to call or write for other information

Sincerely yo 3

Ff kur

E. es Britt, M.D.
ECMO Froject Officer
Division of Lung Diseases

Enclosures